Cardiomyopathy, other and unspecified

I9_CARDMYOOTH

cardiomyopathy: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42.8, I42.9 Hospital discharge: ICD-9 — 4259X Hospital discharge: ICD-8 — 425 Cause of death: ICD-10 — I42.8, I42.9 Cause of death: ICD-9 — 4259X Cause of death: ICD-8 — 425 2 out of 7 registries used, show all original rules.	3205
4. Check minimum number of events None	3205
5. Include endpoints None	3205
6. Filter based on genotype QC (FinnGen only)	3205

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	I9_CARDMYOOTH
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I428\|I429
HD_ICD_9	4259X
HD_ICD_8	425
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I428\|I429
COD_ICD_9	4259X
COD_ICD_8	425
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiomyopathy, other and unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23467	8732	14423
Only index persons	17151	6748	10403
Unadjusted period prevalence (%)
Whole population	0.35	0.25	0.40
Only index persons	0.34	0.25	0.40
Median age at first event (years)
Whole population	60.50	63.47	58.75
Only index persons	60.78	63.42	59.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3205	1288	1917
Unadjusted period prevalence (%)	0.68	0.44	0.85
Median age at first event (years)	60.07	60.66	59.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2922: Matched controls
29219

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XF404

NOMESCO Finland

Ambulatory ECG

28.7

323.0

841

405

C09AA05

ATC

ramipril; oral

6.8

323.0

1500

3944

I50.9

ICD-10 Finland

Heart failure, unspecified

329.8

323.0

1394

I50.1

ICD-10 Finland

Left ventricular failure

10246.7

323.0

773

201

Kela drug reimbursment

Chronic cardiac insufficiency

155.5

323.0

1193

129

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

463.4

323.0

725

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

628

C01AA05

ATC

digoxin; systemic

63.1

323.0

710

148

I42.0

ICD-10 Finland

Dilated cardiomyopathy

16384.0

323.0

1318

I47.2

ICD-10 Finland

Ventricular tachycardia

910.3

323.0

395

B01AA03

ATC

warfarin; systemic

18.9

323.0

1323

1225

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

719.3

323.0

713

I48

ICD-10 Finland

Atrial fibrillation and flutter

178.9

323.0

1342

138

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

323.0

597

AN1

Coronary angiography

9.4

323.0

896

1306

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

12.5

323.0

1335

1841

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

22.9

323.0

1625

1512

C03DA01

ATC

spironolactone; oral

25.7

323.0

1262

840

C03CA01

ATC

furosemide; systemic

13.3

323.0

1820

3228

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

13.3

323.0

1669

2666

C07AB07

ATC

bisoprolol; oral

12.4

323.0

2332

7058

C01BD01

ATC

amiodarone; systemic

505.1

323.0

434

TFP20

NOMESCO Finland

Cardiodefibrillation

237.2

323.0

542

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4503599627370496.0

323.0

2290

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1110.9

323.0

616

I50.0

ICD-10 Finland

Congestive heart failure

554.7

323.0

752

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

498.8

323.0

894

207

Kela drug reimbursment

Chronic arrhythmias

608.5

323.0

990

K78

ICPC

Atrial fibrillation/flutter

32.3

303.1

406

145

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

211.8

297.0

304

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.5

292.2

885

1842

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

287.3

271

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

284.9

1775

7888

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

272.2

257

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

11.2

269.6

542

580

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

267.9

265.2

268

B01AF02

ATC

apixaban; oral

18.9

264.9

419

256

I49.3

ICD-10 Finland

Ventricular premature depolarization

28.4

254.2

352

140

C09DX04

ATC

valsartan and sacubitril; oral

+∞

248.5

235

GD1LA

NOMESCO Finland

203.6

236.2

243

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

156.4

232.5

244

XF400

NOMESCO Finland

ECG with 12 standard connections

5.1

232.5

867

2231

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

+∞

231.3

219

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

180.6

224.5

233

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

204.9

220.6

227

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

219.6

208

TFP34

NOMESCO Finland

Electrophysiological investigation

1129.0

217.4

210

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

217.4

206

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2051.2

210.9

202

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

2005.9

206.6

198

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

11.4

201.7

398

399

I50

ICD-10 Finland

Heart failure

44.0

200.7

250

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

135.0

200.2

213

R06.0

ICD-10 Finland

Dyspnoea

3.9

190.1

981

3355

WX892

NOMESCO Finland

Monitored bed care

7.4

187.7

484

762

I49.5

ICD-10 Finland

Sick sinus syndrome

245.2

180.6

184

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

179.0

170

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

62.1

177.7

208

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.7

169.1

898

3093

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

165.2

157

I47.1

ICD-10 Finland

Supraventricular tachycardia

67.6

164.5

190

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

339.2

161.7

162

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

+∞

157.7

150

I48.1

ICD-10 Finland

Persistent atrial fibrillation

799.4

155.9

152

XF402

NOMESCO Finland

ECG with work load test

5.2

155.7

543

1238

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

7.8

155.4

382

552

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

760.5

148.5

145

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

143.9

137

C07AA07

ATC

sotalol; systemic

15.2

141.9

242

172

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

141.8

135

I48.2

ICD-10 Finland

Chronic atrial fibrillation

+∞

139.7

133

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

132.3

126

M04AA01

ATC

allopurinol; systemic

4.0

131.0

610

1825

AP1

Catheterization of the left side of the heart

22.6

128.3

189

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

228.4

127.9

131

XF640

NOMESCO Finland

17.9

127.7

204

122

K77

ICPC

Heart failure

43.9

127.0

158

Angiography of the heart and coronary arteries

6.4

125.4

354

615

R4110

NOMESCO Finland

Physiotherapy

2.8

124.2

1022

4637

C01BC04

ATC

flecainide; systemic

135.9

122.1

130

TFJ02

NOMESCO Finland

Muscle biopsy of heart

+∞

120.6

115

TPH04

NOMESCO Finland

Cathetrisation of vein

3.1

120.5

795

3102

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

7.0

117.8

310

488

I35.0

ICD-10 Finland

Aortic (valve) stenosis

39.9

116.7

148

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

590.7

115.8

114

1CX08

NOMESCO Finland

392.2

114.3

114

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.4

113.6

645

2243

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

113.2

108

ZX120

NOMESCO Finland

Intravenous

4.3

111.2

462

1230

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

10.6

111.1

224

227

TPH07

NOMESCO Finland

Cathetrisation of artery

4.1

110.7

485

1356

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

9.4

108.3

234

269

I42

ICD-10 Finland

Cardiomyopathy

+∞

106.9

102

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

106.9

102

TFP35

NOMESCO Finland

Electroanatomical mapping

1065.6

106.0

103

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

278.3

105.6

107

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

+∞

103.7

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

+∞

100.6

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

24.4

100.3

144

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

6.0

98.3

290

528

Z94.1

ICD-10 Finland

Heart transplant status

477.6

93.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

93.7

828

3795

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

93.5

892

4270

K84

ICPC

Heart disease other

13.2

92.8

167

133

C07AB02

ATC

metoprolol; systemic

2.9

92.6

692

2863

I34.1

ICD-10 Finland

Mitral (valve) prolapse

96.0

92.6

102

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.7

92.1

776

3452

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

100.3

88.5

AP4

Myocardial biopsy

+∞

87.9

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

4.5

86.7

335

820

A12BA01

ATC

potassium chloride; oral

6.8

85.0

225

353

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

19.5

83.8

129

WX872

NOMESCO Finland

Intensive care

6.0

82.6

241

430

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

14.3

82.3

143

105

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

80.8

547

2102

M10.9

ICD-10 Finland

Gout, unspecified

4.5

79.4

303

731

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

77.4

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.7

77.3

367

1080

I44.1

ICD-10 Finland

Atrioventricular block, second degree

162.2

75.4

XFE00

NOMESCO Finland

Epicardial ultrasonography

11.9

74.8

141

124

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

93.7

74.3

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

74.3

C07AG02

ATC

carvedilol; oral

4.3

73.3

294

742

AQ1

Conventional electrophysiological examination

725.6

72.4

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

72.2

B01AB05

ATC

enoxaparin; parenteral

2.2

71.9

959

5292

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

360.7

70.9

C01DA14

ATC

isosorbide mononitrate; oral

2.9

70.6

501

1968

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.8

70.2

327

944

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

70.1

AS7

Arrhythmia pacemaker insertion VVI (R) S

694.1

69.3

AS4

Physiological pacemaker insertion DDD (R)

344.9

67.8

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

37.1

64.7

H02AB06

ATC

prednisolone; systemic

2.0

64.4

1366

9017

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

63.8

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

+∞

62.7

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

62.7

I25.2

ICD-10 Finland

Old myocardial infarction

4.2

61.7

254

654

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.2

61.5

252

646

AA1AD

NOMESCO Finland

CT of head and brain

2.2

61.2

745

3887

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

60.6

I51.4

ICD-10 Finland

Myocarditis, unspecified

599.9

59.9

127

Kela drug reimbursment

Transplant complication

10.6

59.7

119

117

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4.5

59.3

224

531

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

7.3

59.1

147

210

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.5

58.9

297

910

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

58.5

R02

ICPC

Shortness of breath/dyspnoea

2.9

58.0

385

1436

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

+∞

57.5

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

57.5

B01AE07

ATC

dabigatran etexilate; oral

8.2

56.7

131

167

C08DA01

ATC

verapamil; systemic

6.5

56.1

152

245

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

103.8

56.0

Electrophysiological Special Examination

79.2

55.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

55.1

448

1889

L04AA06

ATC

mycophenolic acid; systemic

9.3

54.7

117

131

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

547.8

54.7

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.3

54.5

565

2709

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

54.3

FL1AC

NOMESCO Finland

Left cardioangiography

11.9

53.4

100

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

53.3

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

9.0

53.1

115

132

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.4

53.0

166

321

R00.1

ICD-10 Finland

Bradycardia, unspecified

8.8

52.6

116

137

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

52.2

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

51.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

51.1

604

3075

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.0

50.2

212

557

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

50.0

846

4995

WX740

NOMESCO Finland

Nitrogen oxide therapy

110.0

49.9

A46

ICD-10 Finland

Erysipelas

2.5

49.2

448

2002

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

49.1

517

2485

Initial pacemaker installation

+∞

49.1

42508

ICD-8 Finland

Cardiomyopathy, Alia definita

+∞

49.1

WX722

NOMESCO Finland

PEEP

4.1

48.8

200

511

3AC01

NOMESCO Finland

17.0

48.7

C09AA04

ATC

perindopril; oral

3.7

48.7

227

650

TKC20

NOMESCO Finland

Catheterisation of bladder

3.2

48.6

273

903

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.6

48.5

234

689

K99

ICPC

Cardiovascular disease other

7.8

48.5

115

153

TK800

NOMESCO Finland

Hemodialysis

7.6

48.2

116

158

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

48.0

I45.9

ICD-10 Finland

Conduction disorder, unspecified

90.0

48.0

R55

ICD-10 Finland

Syncope and collapse

2.7

47.8

352

1390

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.3

46.8

182

443

C09AA02

ATC

enalapril; systemic

2.1

46.4

635

3428

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

46.2

307

1138

AP2

Catheterization of the right side of the heart

86.5

46.0

AP3

Catheterization of the right and left side of the heart

+∞

45.9

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.8

45.8

325

1256

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

45.6

714

4064

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

74.2

45.1

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

44.9

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

44.9

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

44.4

325

1277

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

43.8

C10AA01

ATC

simvastatin; oral

1.7

43.6

1296

9160

XF409

NOMESCO Finland

Other special ECG

48.0

43.0

XF600

NOMESCO Finland

Bloodpressure measurement

3.4

42.6

220

683

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.7

42.2

125

226

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

42.1

798

4852

B01AF01

ATC

rivaroxaban; oral

2.7

41.3

311

1243

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

41.2

567

3048

R03AC02

ATC

salbutamol; inhalant

1.7

40.8

1341

9697

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

+∞

40.7

R53

ICD-10 Finland

Malaise and fatigue

2.1

40.2

531

2805

A02BC02

ATC

pantoprazole; systemic

1.7

40.1

1764

13849

WX002

NOMESCO Finland

Sedation and analgesia

2.0

39.7

585

3225

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

13.2

39.6

C10AA05

ATC

atorvastatin; oral

1.7

39.6

1107

7607

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

58.3

39.3

M10

ICD-10 Finland

Gout

3.7

38.7

178

503

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

38.6

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.5

38.1

142

331

R04.0

ICD-10 Finland

Epistaxis

3.1

37.9

226

775

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

37.8

330

1431

N19

ICD-10 Finland

Unspecified kidney failure

4.7

37.6

133

294

Cardiac muscle biopsy

+∞

37.6

I20.09

ICD-10 Finland

Unstable angina

3.4

36.6

185

564

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

+∞

36.5

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

+∞

36.5

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

+∞

36.5

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

36.5

250

Kela drug reimbursment

+∞

36.5

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.5

36.2

179

537

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

36.1

470

2455

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

44.6

36.0

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

35.7

268

1066

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

+∞

35.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

35.4

785

4981

B01AF03

ATC

edoxaban; oral

29.8

35.2

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

7.5

34.9

115

ZX108

NOMESCO Finland

Inhalation

12.9

34.8

7AX01

NOMESCO Finland

124.8

34.7

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

+∞

34.4

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

34.4

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.1

34.3

162

3A064

NOMESCO Finland

57.9

34.2

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.9

33.6

144

383

K80

ICPC

Cardiac arrhythmia NOS

3.3

33.4

175

548

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

33.4

WX730

NOMESCO Finland

Conventional respirator

8.0

32.6

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

32.3

AS2

Ventricular pacemaker insertion VVI (R)

+∞

32.3

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

6.4

31.7

136

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.6

31.6

129

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

22.8

31.3

Initial installation of the atrial pacemaker

+∞

31.3

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.0

31.0

148

A11CC03

ATC

alfacalcidol; systemic

5.5

31.0

172

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.5

31.0

262

1113

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

30.9

195

696

N02BE01

ATC

paracetamol; systemic, rectal

1.7

30.9

2321

20262

TK810

NOMESCO Finland

Hemofiltration

15.2

30.8

WX882

NOMESCO Finland

High dependency care

4.4

30.8

116

274

E87.5

ICD-10 Finland

Hyperkalaemia

7.9

30.2

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

30.1

411

2178

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

30.0

308

1441

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.2

29.9

167

548

R50.9

ICD-10 Finland

Fever, unspecified

2.1

29.9

374

1913

I49.1

ICD-10 Finland

Atrial premature depolarization

7.7

29.8

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

156.5

29.7

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

29.2

342

Kela drug reimbursment

Dronedarone

+∞

29.2

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

+∞

29.2

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

4.9

29.2

206

N02AX02

ATC

tramadol; systemic, rectal

1.6

29.2

1147

8452

Catheter ablation of arrhythmia

294.7

28.8

A10BK01

ATC

dapagliflozin; oral

3.1

28.8

163

539

A10AE04

ATC

insulin glargine; parenteral

2.3

28.7

272

1223

K83

ICPC

Heart valve disease NOS

34.0

28.7

Z50.0

ICD-10 Finland

Cardiac rehabilitation

8.7

28.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.2

28.3

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

28.3

158

519

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

28.2

753

4992

M10.0

ICD-10 Finland

Idiopathic gout

3.9

28.2

121

323

N05CF01

ATC

zopiclone; oral

1.6

28.2

851

5841

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

28.2

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

4.6

28.0

220

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

64.6

27.9

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

284.0

27.8

Catheterization and pressure measurement of the right side of the heart

42.9

27.7

E05.89

ICD-10 Finland

Other thyrotoxicosis

42.9

27.7

I44.0

ICD-10 Finland

Atrioventricular block, first degree

17.4

27.5

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.2

27.4

286

1347

AQ2

Electrophysiological electroanatomical examination

+∞

27.1

N18.8

ICD-10 Finland

Other chronic renal failure

4.4

26.9

100

234

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.2

26.7

103

250

R03BB04

ATC

tiotropium bromide; inhalant

2.2

26.6

295

1428

R2110

NOMESCO Finland

Giving the first information

2.8

26.6

183

690

RS221

NOMESCO Finland

5.9

26.6

129

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

26.3

830

5739

J01FF01

ATC

clindamycin; systemic

1.7

26.3

694

4571

J01DB01

ATC

cefalexin; oral

1.6

26.1

2173

18889

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

+∞

26.1

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

26.1

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

26.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

26.0

281

1343

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

26.0

197

786

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.7

25.9

117

327

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

5.2

25.7

159

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

25.7

194

770

Catheterization and pressure measurement of the left side of the heart

5.9

25.7

127

742

NOMESCO Finland

44.7

25.5

H03BB01

ATC

carbimazole; oral

3.6

25.4

117

332

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

+∞

25.0

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

25.0

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

+∞

25.0

H02AB07

ATC

prednisone; oral

1.9

25.0

400

2242

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.5

24.8

211

896

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

24.8

913

6548

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

70.5

24.8

S97

ICPC

Chronic ulcer skin

2.9

24.8

158

567

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.1

24.6

140

465

J01CA04

ATC

amoxicillin; systemic

1.5

24.4

2059

17766

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

22.1

24.3

Z71.8

ICD-10 Finland

Other specified counselling

1.7

24.2

561

3544

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

10.1

24.2

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.6

24.1

191

779

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

24.1

1548

12563

XFP02

NOMESCO Finland

+∞

24.0

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

24.0

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

24.0

J01MA12

ATC

levofloxacin; systemic

1.8

24.0

501

3067

R42

ICD-10 Finland

Dizziness and giddiness

1.7

23.9

531

3314

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.5

23.9

200

842

L04AX01

ATC

azathioprine; systemic

3.0

23.8

139

472

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

15.2

23.7

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

126.0

23.6

WX930

NOMESCO Finland

Thepapeutic hypothermia

126.0

23.6

C08DB01

ATC

diltiazem; oral

2.9

23.6

151

544

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

23.4

178

711

R4120

NOMESCO Finland

Occupational therapy

2.5

23.4

187

769

C01BA03

ATC

disopyramide; systemic

33.6

23.3

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

23.1

201

865

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

23.0

1156

8871

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

22.9

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

22.9

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

22.9

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

22.9

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

22.9

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

22.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.1

22.7

129

428

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.9

22.6

245

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

22.6

103

291

ZXA05

NOMESCO Finland

Left side

1.6

22.2

691

4725

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

22.2

198

863

C01BA01

ATC

quinidine; oral

52.4

22.1

R07.3

ICD-10 Finland

Other chest pain

2.2

22.1

238

1136

I51.9

ICD-10 Finland

Heart disease, unspecified

+∞

21.9

C01BD07

ATC

dronedarone; oral

+∞

21.9

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

21.9

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

21.9

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

+∞

21.9

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

21.6

568

3712

FXE00

NOMESCO Finland

Use of ECLA

221.5

21.6

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

221.5

21.6

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

21.6

486

3034

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

21.6

290

1517

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

21.5

129

445

B01AB04

ATC

dalteparin; parenteral

2.8

21.3

146

548

L28

ICPC

Limited function/disability (L)

1.8

21.1

408

2429

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

20.9

750

5299

WX902

NOMESCO Finland

External defibrillation of heart

211.3

20.6

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.8

20.5

133

483

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

20.5

658

4522

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.5

20.5

278

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

17.0

20.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

20.3

883

6517

C03AA03

ATC

hydrochlorothiazide; oral

2.1

20.2

251

1271

A10BA02

ATC

metformin; oral

1.5

20.2

743

5276

C01BB02

ATC

mexiletine; systemic

32.8

20.2

C09CA01

ATC

losartan; oral

1.6

20.1

616

4182

I20.00

ICD-10 Finland

Unstable angina

3.4

20.0

288

UJF32

NOMESCO Finland

Coloscopy

1.6

19.9

659

4558

C09AA01

ATC

captopril; oral

4.6

19.9

152

AK1

HTX (heart transplant)

+∞

19.8

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

+∞

19.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

19.7

133

497

XF406

NOMESCO Finland

High resolution ECG

105.7

19.6

R4190

NOMESCO Finland

Nutritional therapy

3.2

19.4

103

328

L04AD01

ATC

ciclosporin; systemic

4.2

19.4

179

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

19.2

510

3333

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

19.1

195

905

5AB14

NOMESCO Finland

26.2

19.1

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

19.1

111

377

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

11.4

18.9

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.1

18.9

105

346

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

18.8

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

18.8

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

+∞

18.8

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

18.8

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

18.7

161

689

A28

ICPC

Limited function/disability NOS

1.8

18.5

372

2237

I44.6

ICD-10 Finland

Other and unspecified fascicular block

191.1

18.5

ZX197

NOMESCO Finland

38.6

18.5

J81

ICD-10 Finland

Pulmonary oedema

15.1

18.4

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.9

18.3

125

I45.6

ICD-10 Finland

Pre-excitation syndrome

44.3

18.2

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

44.3

18.2

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

18.2

1985

22075

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

18.0

127

486

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.1

17.9

174

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

17.8

175

800

B01AC04

ATC

clopidogrel; oral

1.7

17.8

396

2455

G04BE03

ATC

sildenafil; oral

4.1

17.8

175

C09CA03

ATC

valsartan; oral

2.0

17.8

237

1234

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

17.7

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

17.7

AC4

MVP

+∞

17.7

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

17.7

I48.3

ICD-10 Finland

Typical atrial flutter

67.0

17.7

I45.2

ICD-10 Finland

Bifascicular block

67.0

17.7

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.1

17.7

M79.6

ICD-10 Finland

Pain in limb

1.5

17.6

828

6174

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

95.6

17.6

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

181.0

17.5

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.0

17.4

102

349

S18

ICPC

Laceration/cut

1.4

17.3

1078

8489

K04

ICPC

Palpitations/awareness of heart

2.9

17.2

104

361

XF602

NOMESCO Finland

Bloodpressure monitoring

7.0

17.1

R04.2

ICD-10 Finland

Haemoptysis

3.0

17.0

101

349

WX110

NOMESCO Finland

Local anesthesy

1.4

16.9

1694

14511

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.0

16.9

102

353

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

16.9

158

706

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

25.7

16.9

K05

ICPC

Irregular heartbeat other

4.2

16.9

155

XW000

NOMESCO Finland

Bone marrow biopsy

2.7

16.9

120

463

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

16.8

635

4508

FM1CD

NOMESCO Finland

Very extensive CT of heart

63.7

16.7

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

63.7

16.7

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

63.7

16.7

K29

ICPC

Cardiovascular sympt/complt other

2.8

16.7

109

400

J01MA14

ATC

moxifloxacin; systemic

2.0

16.7

225

1178

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

+∞

16.7

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

+∞

16.7

AB2

AVR bio, stent

+∞

16.7

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

16.7

AS5

Biventricular heart failure pacemaker insertion VVI (R)

+∞

16.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

16.7

340

2052

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.9

16.6

I95.9

ICD-10 Finland

Hypotension, unspecified

5.7

16.6

N17.8

ICD-10 Finland

Other acute renal failure

6.6

16.6

F1279

NOMESCO Finland

90.6

16.6

G47.3

ICD-10 Finland

Sleep apnoea

1.6

16.5

523

3558

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

170.9

16.5

I49.2

ICD-10 Finland

Junctional premature depolarization

170.9

16.5

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

16.4

137

576

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

16.3

274

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

7.8

16.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

16.2

779

5814

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

16.2

163

755

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.5

16.1

129

532

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

16.1

308

1820

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.5

16.0

213

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.0

16.0

311

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

15.9

101

363

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

60.3

15.8

3A149

NOMESCO Finland

60.3

15.8

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

5.0

15.6

102

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

+∞

15.6

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

15.6

AR5

Catheter ablation of arrhythmia, target: atrial flutter

+∞

15.6

WX890

NOMESCO Finland

Intesive care monitoring

7.0

15.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

15.6

154

706

I51.7

ICD-10 Finland

Cardiomegaly

85.5

15.6

WX402

NOMESCO Finland

General anaesthesia

1.7

15.6

387

2473

R00.2

ICD-10 Finland

Palpitations

2.4

15.5

131

554

RS220

NOMESCO Finland

4.9

15.5

103

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

160.8

15.5

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

160.8

15.5

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

15.4

195

996

A10BH01

ATC

sitagliptin; oral

1.8

15.4

255

1436

A12AA04

ATC

calcium carbonate; oral

5.0

15.3

100

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

15.3

938

7321

C08CA02

ATC

felodipine; oral

1.9

15.3

243

1350

A10AE05

ATC

insulin detemir; parenteral

2.3

15.3

138

605

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

15.2

246

1378

K79

ICPC

Paroxysmal tachycardia

23.5

15.1

ZXA00

NOMESCO Finland

Right side

1.5

15.0

692

5108

M01AH05

ATC

etoricoxib; oral

0.7

15.0

1041

12642

E66.8

ICD-10 Finland

Other obesity

2.6

14.9

108

421

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

14.9

131

569

R11

ICD-10 Finland

Nausea and vomiting

2.1

14.9

177

880

T90

ICPC

Diabetes non-insulin dependent

1.5

14.8

597

4283

R60.0

ICD-10 Finland

Localized oedema

1.8

14.8

257

1473

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

31.8

14.8

120

NOMESCO Finland

56.9

14.8

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

14.7

322

1985

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

6.6

14.6

AT7

Replacing the pacemaker VVI (R) S

+∞

14.6

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

14.6

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

14.6

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

14.6

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

+∞

14.6

I45.3

ICD-10 Finland

Trifascicular block

+∞

14.6

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.9

14.6

303

A10BB12

ATC

glimepiride; oral

2.0

14.5

185

945

J01AA02

ATC

doxycycline; systemic

1.4

14.4

2016

18013

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

14.4

249

132

Kela drug reimbursment

Sarcoidosis

6.2

14.4

N18.0

ICD-10 Finland

End-stage renal disease

6.0

14.3

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.0

14.3

178

903

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

27.3

14.3

C07AB03

ATC

atenolol; systemic

2.2

14.2

150

710

A10BK03

ATC

empagliflozin; oral

2.0

14.2

183

940

L04AA01

ATC

[U] ciclosporin; systemic

4.0

14.2

142

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

14.1

119

505

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

14.1

210

1142

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

4.6

14.0

106

212

Kela drug reimbursment

Gout

3.6

14.0

179

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.7

14.0

169

ZXA10

NOMESCO Finland

Bilateral

1.5

13.9

459

3144

2BD01

NOMESCO Finland

30.2

13.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

13.9

245

1410

AA1

Conventional CABG

3.7

13.8

160

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

13.8

197

SPAT1263

SPAT

Sampling

1.4

13.8

981

7831

SPAT1097

SPAT

Recording of ECG

1.6

13.6

334

2121

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.5

13.6

110

456

205

Kela drug reimbursment

Chronic hypertension

1.4

13.6

703

5298

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

13.5

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

140.6

13.5

XX3BW

NOMESCO Finland

140.6

13.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

13.4

175

904

A10BH05

ATC

linagliptin; oral

2.3

13.4

123

543

J96.0

ICD-10 Finland

Acute respiratory failure

5.6

13.4

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

5.6

13.4

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

13.4

155

C10AA03

ATC

pravastatin; oral

2.0

13.3

183

966

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

13.3

274

1656

R03BA02

ATC

budesonide; inhalant

1.6

13.2

384

2547

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.0

13.2

251

WVA20

NOMESCO Finland

Medicine administration

3.3

13.2

199

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

13.1

153

757

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

13.0

176

922

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.6

13.0

378

WW200

NOMESCO Finland

Immunization

2.8

13.0

297

T92

ICPC

Gout

3.4

12.9

186

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.5

12.9

401

XF622

NOMESCO Finland

Measurement of minute volume of heart

14.1

12.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

12.7

936

7486

J01DA01

ATC

[U] cefalexin; systemic

1.3

12.7

1543

13340

5CM18

NOMESCO Finland

12.3

12.6

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.4

12.6

110

478

RS222

NOMESCO Finland

4.5

12.5

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

12.5

C01BC03

ATC

propafenone; systemic

+∞

12.5

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

+∞

12.5

Aortic Valve Replacement (AVR)

+∞

12.5

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

+∞

12.5

AB1

AVR mechanical

+∞

12.5

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

+∞

12.5

GEA00

NOMESCO Finland

Mediastinoscopy

8.7

12.5

TGC00

NOMESCO Finland

Bronchial lavation

2.9

12.5

252

TFN04

NOMESCO Finland

10.1

12.5

RS230

NOMESCO Finland

9.3

12.5

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.7

12.4

305

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

12.4

312

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

12.4

175

935

N05BA04

ATC

oxazepam; oral

1.5

12.3

547

3989

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

12.3

283

1768

D86.0

ICD-10 Finland

Sarcoidosis of lung

4.4

12.3

K92.1

ICD-10 Finland

Melaena

2.2

12.2

128

603

I11

ICD-10 Finland

Hypertensive heart disease

9.7

12.2

B03XA02

ATC

darbepoetin alfa; parenteral

3.7

12.2

147

A10BJ02

ATC

liraglutide; parenteral

3.1

12.2

211

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

12.2

401

2741

FXG00

NOMESCO Finland

Insertion and use of IABP

15.9

12.1

N30.0

ICD-10 Finland

Acute cystitis

1.7

12.1

273

1696

A07AA02

ATC

nystatin; oral

2.0

12.1

158

817

XG466

NOMESCO Finland

Sleep oxymetry

2.6

12.1

323

B01AB10

ATC

tinzaparin; parenteral

1.9

12.0

170

905

Q23.11

ICD-10 Finland

Bicuspid aortic valve

18.1

12.0

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

8.7

12.0

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

12.0

1166

9719

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

5.4

11.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

11.9

258

1583

XG405

NOMESCO Finland

Education on PEF monitoring

4.0

11.8

116

R05

ICD-10 Finland

Cough

1.5

11.8

435

3048

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

11.8

245

Z94.0

ICD-10 Finland

Kidney transplant status

4.8

11.7

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.7

11.7

292

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

65.2

11.6

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

65.2

11.6

A06AD11

ATC

lactulose; oral

1.6

11.6

350

2341

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.8

11.5

124

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.3

11.5

105

465

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

11.5

202

1164

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.1

11.5

4278X

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[DYSRHYTMIAE CORDIS ALIA DEFINITA]

+∞

11.5

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

11.5

FA1AC

NOMESCO Finland

Upper cavography

+∞

11.5

GBB00

NOMESCO Finland

Tracheostomy

4.0

11.5

110

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

11.4

400

2770

I40.0

ICD-10 Finland

Infective myocarditis

120.4

11.4

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

120.4

11.4

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

11.4

179

994

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

11.3

182

1017

J01FA06

ATC

roxithromycin; oral

1.3

11.3

922

7467

SPAT1255

SPAT

Intravenous administration of medicine

2.0

11.3

152

797

3A422

NOMESCO Finland

35.1

11.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

11.1

341

2290

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.8

11.1

J94.8

ICD-10 Finland

Other specified pleural conditions

3.8

11.1

123

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

25.1

11.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

11.0

140

718

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

11.2

11.0

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

11.0

100

445

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

10.1

11.0

I45.8

ICD-10 Finland

Other specified conduction disorders

43.5

10.9

N05BA01

ATC

diazepam; systemic, rectal

1.6

10.9

306

2012

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

10.9

386

2680

WX900

NOMESCO Finland

Resuscitation

8.3

10.8

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.1

10.8

102

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

17.9

10.7

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.8

10.7

A01

ICPC

Pain general/multiple sites

1.9

10.6

161

881

SPAT1285

SPAT

Provision of consultation response

2.0

10.6

131

666

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

10.6

135

694

I44.4

ICD-10 Finland

Left anterior fascicular block

60.2

10.6

3A560

NOMESCO Finland

60.2

10.6

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.9

10.6

109

XF620

NOMESCO Finland

Examination of circulation with color method

11.2

10.5

J45

ICD-10 Finland

Asthma

1.7

10.5

207

1236

K28

ICPC

Limited function/disability (K)

3.2

10.5

172

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.1

10.5

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.5

10.5

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

+∞

10.4

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

10.4

AD1

TVP

+∞

10.4

5401

FHL

Pacemaker installation, transvenous electrode

+∞

10.4

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

+∞

10.4

42728

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis alia

+∞

10.4

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

10.4

4260A

ICD-9 Finland

Conduction disorders, Atrioventricular block, complete

+∞

10.4

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

+∞

10.4

5244

FHL

Heart transplantation

+∞

10.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

10.4

416

2961

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

16.1

10.3

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

32.6

10.3

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.0

10.3

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.4

10.3

RD210

NOMESCO Finland

3.3

10.3

148

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.9

10.3

107

A04

ICPC

Weakness/tiredness general

1.6

10.3

253

1607

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

10.3

146

782

R06

ICPC

Nose bleed/epistaxis

3.2

10.2

159

C02DE01

ATC

5.8

10.2

K90

ICPC

Stroke/cerebrovascular accident

2.6

10.2

279

I95.2

ICD-10 Finland

Hypotension due to drugs

6.6

10.2

SPAT1262

SPAT

Handing over of treatment supplies

1.5

10.1

437

3158

C02EA01

ATC

4.1

10.1

WW500

NOMESCO Finland

Blood transfusion

2.2

10.1

436

A02BC01

ATC

omeprazole; systemic

1.4

10.1

627

4848

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

10.0

117

580

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

6.5

10.0

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

10.0

278

E86

ICD-10 Finland

Volume depletion

2.8

9.9

223

ZZA00

NOMESCO Finland

Split skin graft

2.6

9.9

279

C02EA02

ATC

2.1

9.9

105

502

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.3

9.9

142

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.6

9.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

9.8

154

854

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

9.8

128

664

I45.0

ICD-10 Finland

Right fascicular block

10.6

9.8

A29

ICPC

General symptom/complaint other

1.6

9.8

245

1565

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

9.7

404

2894

C09CA06

ATC

candesartan; oral

1.4

9.7

474

3507

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

9.7

110

538

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

9.6

334

2307

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

9.6

673

5296

SPAT1325

SPAT

Vaccination

1.3

9.6

838

6823

SPAT1104

SPAT

Monitoring of emergency patient

1.9

9.5

137

739

K60

ICPC

Cardiovascular, Result test/procedure

6.4

9.5

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

10.0

9.5

TK830

NOMESCO Finland

Ultrafiltration

100.3

9.4

FM1AD

NOMESCO Finland

CT of heart

30.1

9.4

E85.9

ICD-10 Finland

Amyloidosis, unspecified

17.6

9.4

F1246

NOMESCO Finland

17.6

9.4

J01CF05

ATC

flucloxacillin; systemic

2.3

9.4

353

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.3

9.4

353

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

9.4

ASX

Other pacemaker insertion

+∞

9.4

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

+∞

9.4

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

9.4

4263A

ICD-9 Finland

Conduction disorders, Other left bundle branch block

+∞

9.4

TFP43

NOMESCO Finland

Ablation treatment for atrial tachycardia

+∞

9.4

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

9.4

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

9.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

9.4

270

1788

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

9.4

110

549

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.6

9.3

112

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

9.3

243

1567

C10AA07

ATC

rosuvastatin; oral

1.4

9.3

577

4451

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

4.5

9.1

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.1

9.1

101

490

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.7

9.1

104

SPAT1260

SPAT

Consultation of another employee

1.4

9.1

390

2816

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.1

9.1

446

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

15.6

9.0

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

9.0

209

1309

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.2

9.0

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

8.9

354

J20

ICD-10 Finland

Acute bronchitis

1.6

8.9

208

1302

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

8.9

154

886

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.8

8.8

205

SPAT1281

SPAT

Other administrative function

1.7

8.8

179

1078

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

8.8

331

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

9.5

8.8

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

3.4

8.8

118

K22

ICPC

Risk factor cardiovascular disease

1.9

8.7

118

622

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

8.7

236

1538

SPAT1251

SPAT

Organisation of medication

2.3

8.7

333

SPAT1254

SPAT

Administration of medicine

1.5

8.7

306

2120

A41.8

ICD-10 Finland

Other specified sepsis

3.2

8.7

135

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.6

8.6

H02AB04

ATC

methylprednisolone; systemic

1.5

8.6

313

2185

1DC02

NOMESCO Finland

8.2

8.6

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.6

8.5

105

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.9

8.5

K06.18

ICD-10 Finland

Another gingival hyperplasia

10.0

8.5

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

8.5

492

EB1WA

NOMESCO Finland

4.9

8.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

8.5

213

1361

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.3

8.5

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.3

8.5

474

NOMESCO Finland

27.6

8.5

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

4.1

8.4

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.8

8.4

131

724

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.0

8.4

155

G71.0

ICD-10 Finland

Muscular dystrophy

90.3

8.4

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

8.4

250

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

8.4

113

597

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.5

8.3

107

T86.2

ICD-10 Finland

Heart transplant failure and rejection

+∞

8.3

4278A

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[SICK SINUS-SYNDROMA]

+∞

8.3

E06.4

ICD-10 Finland

Drug-induced thyroiditis

+∞

8.3

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

+∞

8.3

5409

FHL

Other measure in this category

+∞

8.3

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

+∞

8.3

5403

FHL

Replacing the pacemaker

+∞

8.3

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

8.3

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

+∞

8.3

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

8.3

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

8.3

AT4

Physiological pacemaker replacement DDD (R)

+∞

8.3

AT6

Biventricular physiological heart failure pacemaker replacement DDD (R)

+∞

8.3

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

8.3

578

4532

349

Kela drug reimbursment

Febuxostat

10.8

8.3

C10AX09

ATC

ezetimibe; oral

1.6

8.3

240

1591

SPAT1211

SPAT

Application of soft bandage

1.6

8.3

192

1203

WX320

NOMESCO Finland

Spinalanesthesy

1.4

8.2

522

4032

FN1AD

NOMESCO Finland

CT of coronary arteries

3.5

8.2

103

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

8.2

152

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

4.8

8.2

A11

ICPC

Chest pain NOS

1.7

8.2

160

956

G71.08

ICD-10 Finland

Other muscular dystrophy

14.5

8.2

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

6.5

8.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.4

8.2

286

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

7.5

8.1

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.5

8.1

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.1

8.1

142

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.0

8.1

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.9

8.1

170

R52.9

ICD-10 Finland

Pain, unspecified

1.7

8.1

171

1044

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

8.1

1636

14715

R03DA04

ATC

theophylline; systemic, rectal

1.9

8.1

117

635

I24.0

ICD-10 Finland

Coronary thrombosis not resulting in myocardial infarction

17.2

8.1

41299

ICD-8 Finland

Chronic ischaemic heart disease, Without mention of hypertensive disease

11.7

8.1

Q21.10

ICD-10 Finland

Persistent ostium secundum

11.7

8.1

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

11.7

8.1

GD1UN

NOMESCO Finland

Lung circulation SPECT

6.8

8.1

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.0

8.0

149

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

22.1

8.0

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.9

8.0

166

R18

ICD-10 Finland

Ascites

2.7

8.0

196

M05BA04

ATC

alendronic acid; oral

1.6

7.9

179

1114

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.7

7.9

197

PD5AD

NOMESCO Finland

CT of aorta

3.7

7.9

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

7.9

162

983

N03AX16

ATC

pregabalin; oral

1.4

7.9

509

3945

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

7.9

130

736

W19

ICD-10 Finland

Unspecified fall

1.6

7.8

205

1326

L76

ICPC

Fracture: other

2.4

7.8

272

288

Kela drug reimbursment

Febuxostat

8.5

7.8

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

7.8

324

XF612

NOMESCO Finland

Measurement of central venous pressure

10.8

7.8

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.8

7.7

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

5.9

7.7

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.6

7.7

J46

ICD-10 Finland

Status asthmaticus

2.6

7.6

206

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.5

7.6

239

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.9

7.6

R03BA05

ATC

fluticasone; inhalant

1.4

7.6

364

2678

X57

ICD-10 Finland

Unspecified privation

2.6

7.6

207

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

7.6

394

2940

H02AB09

ATC

hydrocortisone; systemic

2.5

7.6

224

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.0

7.6

138

T82.7

ICD-10 Finland

Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts

18.4

7.6

R05

ICPC

Cough

1.4

7.6

460

3527

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027456) Digoxin [Moles/volume] in Serum or Plasma

272

69.03

307.65

2.9

1.6

0.8

nmol/l

0.02

198

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1016

1506

9.41

307.65

5.2

1.8

364.1

88.0

ng/l

32.72

986

1325

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1184

2980

5.71

307.65

3.5

2.2

2.3

g/l

0.25

1122

2741

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1173

2771

6.10

307.65

3.6

2.3

22.8

24.3

2.73

1071

2338

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1260

4158

4.35

307.65

7.3

2.8

592.7

491.0

ng/l

0.26

1185

3217

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2290

5507

12.06

307.65

7.7

1.8

2401.4

606.8

ng/l

39.20

2158

4485

(3022948) Iron [Moles/volume] in Serum or Plasma

1216

3259

5.40

307.65

3.5

2.2

13.3

13.6

umol/l

0.69

1156

3000

(3022217) INR in Platelet poor plasma by Coagulation assay

905

2255

5.20

307.65

43.4

9.6

1.8

1.1

inr

8.26

411

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1087

3564

4.10

288.31

6.9

3.4

0.8

mmol/l

0.39

1032

3304

(3032080) INR in Blood by Coagulation assay

1911

9138

3.70

285.98

21.3

4.5

1.6

1.1

inr

43.90

512

2451

(3020779) Urea [Moles/volume] in Serum or Plasma

719

1917

4.55

248.67

16.3

6.1

11.7

9.0

mmol/l

16.31

692

1823

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

350

534

7.24

222.43

5.0

2.6

0.3

u/ml

0.16

221

284

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

321

496

7.08

201.19

3.4

1.8

12.1

11.0

mg/l

1.33

300

455

(3000991) Gas panel - Venous blood

628

1789

4.12

195.64

13.0

7.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1657

8608

2.92

190.50

6.5

2.8

56.5

99.1

ng/l

0.38

1344

6000

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1242

5590

2.99

185.17

2.8

2.0

3.0

2.8

mg/l

1.02

1098

4660

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1702

9136

2.84

181.12

4.2

2.5

181.7

156.2

ug/l

0.87

1612

8326

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

577

1649

4.05

177.91

3.6

1.8

20.9

6.3

ug/l

6.07

525

1408

(3014111) Lactate [Moles/volume] in Serum or Plasma

615

1872

3.83

173.03

11.4

6.1

1.5

1.3

mmol/l

2.70

585

1805

(3003458) Phosphate [Moles/volume] in Serum or Plasma

796

2888

3.34

170.50

8.7

5.3

1.1

1.0

mmol/l

12.61

748

2683

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

405

983

4.57

154.17

5.8

3.6

24.0

mmol/l

0.03

376

894

(3018677) aPTT in Platelet poor plasma by Coagulation assay

843

3345

3.06

153.33

4.9

1.8

31.9

29.0

25.02

827

3247

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

382

900

4.68

150.82

3.3

1.7

33.8

39.5

u/l

4.73

291

800

(3033658) Prothrombin time (PT) actual/Normal

1255

6199

2.68

150.27

6.0

3.7

74.3

93.5

85.77

1223

6065

(3018418) pH of Serum or Plasma

1375

7231

2.58

143.12

6.0

3.7

7.4

0.99

241

1303

(3023368) Bacteria identified in Blood by Culture

1279

6505

2.61

142.68

6.2

3.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

589

1993

3.40

138.92

5.7

3.3

5.9

5.8

kpa

2.81

574

1942

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

679

2504

3.17

138.90

11.5

6.5

5.0

5.1

kpa

1.96

648

2395

(3002032) Base excess in Venous blood by calculation

586

1992

3.38

137.07

5.7

3.3

1.8

mmol/l

0.07

497

1585

(3027801) Oxygen [Partial pressure] in Arterial blood

676

2505

3.15

136.99

11.6

6.5

11.3

12.8

kpa

12.29

644

2398

(3003396) Base excess in Arterial blood by calculation

673

2494

3.15

136.32

11.5

6.5

0.6

0.9

mmol/l

1.08

558

1911

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1822

11114

2.48

135.18

10.6

5.3

1.2

mmol/l

29.30

1729

9940

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

663

2457

3.14

134.11

2.2

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

395

1057

4.12

131.53

4.0

3.2

4.2

4.6

pmol/l

8.23

361

929

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

833

3589

2.78

127.39

2.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

653

2466

3.07

127.29

2.1

1.6

—

(3016502) Oxygen saturation in Arterial blood

612

2227

3.16

127.20

12.3

6.9

94.8

96.2

4.05

599

2147

(3014576) Chloride [Moles/volume] in Serum or Plasma

717

2879

2.92

124.97

11.8

6.1

104.0

104.3

mmol/l

0.66

709

2820

(40758558) Short blood count panel - Blood

1187

6138

2.48

124.18

9.4

6.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1958

12655

2.41

122.99

9.3

6.4

14.1

11.6

umol/l

10.75

1890

12024

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

402

1146

3.87

122.20

14.2

8.2

24.1

24.2

mmol/l

0.26

377

1079

(3021589) Normoblasts [#/volume] in Blood

1752

10828

2.36

121.46

13.9

8.8

0.0

e9/l

0.04

1426

8819

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

360

966

4.07

119.03

1.9

1.6

g/l

0.04

317

834

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

659

2593

2.94

118.66

7.6

4.4

265.5

236.7

u/l

3.45

626

2438

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1907

12328

2.35

117.57

11.4

6.0

1.2

mmol/l

28.46

1648

10405

(3001604) Monocytes [#/volume] in Blood

1853

11940

2.31

113.58

8.9

5.7

0.6

e9/l

5.16

1611

10181

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

255

541

5.03

113.49

4.9

2.5

3.5

g/l

0.34

242

519

(3013826) Glucose [Moles/volume] in Serum or Plasma

2110

14393

2.36

112.55

9.0

4.0

6.9

6.8

mmol/l

0.78

2027

13420

(3006315) Basophils [#/volume] in Blood

1855

12008

2.29

111.75

8.9

5.7

0.0

e9/l

1.12

1612

10254

(3052851) Hemolysis interference index of Serum or Plasma

275

637

4.63

110.01

4.8

3.1

—

(3019198) Lymphocytes [#/volume] in Blood

1877

12280

2.28

109.22

8.9

5.8

1.8

2.0

e9/l

3.38

1660

10662

(3013115) Eosinophils [#/volume] in Blood

1886

12409

2.26

107.59

9.5

5.9

0.2

e9/l

2.11

1664

10748

(3022096) Basophils/100 leukocytes in Blood

1719

10908

2.24

106.99

9.2

6.0

0.6

0.7

2.75

1643

10093

(42870588) Differential panel, method unspecified - Blood

1396

8189

2.25

104.86

8.4

5.8

—

(3006504) Eosinophils/100 leukocytes in Blood

1745

11224

2.22

103.93

9.1

5.9

2.7

2.9

3.85

1670

10374

(3019069) Monocytes/100 leukocytes in Blood

1751

11283

2.22

103.75

9.3

6.2

9.1

8.8

3.58

1676

10480

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

286

720

4.26

102.67

4.2

2.1

1064.0

520.5

ug/l

0.50

278

676

(3036489) Thrombin time

297

771

4.14

102.32

4.4

1.9

22.4

21.1

1.57

276

682

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

258

607

4.53

101.05

4.9

2.1

88.2

92.0

1.72

251

570

(3002030) Lymphocytes/100 leukocytes in Blood

1767

11573

2.17

98.59

9.3

6.0

24.7

28.1

30.54

1693

10675

(3044889) 12 lead EKG panel

2402

17818

2.39

98.11

7.4

3.1

—

(3018010) Neutrophils/100 leukocytes in Blood

1746

11411

2.16

97.59

9.0

5.8

60.0

56.9

22.85

1670

10602

(3024354) Oxygen [Partial pressure] in Venous blood

460

1639

3.11

97.51

4.7

2.8

4.7

4.5

kpa

0.58

443

1595

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1251

7237

2.20

94.91

2.9

2.0

360.6

218.5

u/l

0.61

1188

6748

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

924

4789

2.31

91.05

4.8

1.6

1.5

1.3

mg/l

0.54

715

3721

(3030467) Casts [#/volume] in Urine by Automated count

1208

6990

2.17

90.63

3.9

3.1

1.0

0.4

e6/l

2.07

944

5209

(36304419) Bacteria [Presence] in Urine

1176

6759

2.17

89.53

3.9

3.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2001

14058

2.13

89.22

11.7

9.3

4.4

4.1

e9/l

5.43

1748

12203

(3026250) Tacrolimus [Mass/volume] in Blood

10.97

88.23

36.2

33.9

7.8

7.3

ug/l

1.03

(3027945) Reticulocytes/100 erythrocytes in Blood

598

2620

2.58

84.95

2.5

2.4

1.9

1.7

5.46

539

2282

(3020630) Protein [Mass/volume] in Serum or Plasma

489

1947

2.78

84.02

2.4

2.6

64.8

67.0

g/l

7.38

447

1753

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

598

2641

2.55

83.42

2.9

9.0

9.2

umol/l

0.06

540

2327

(3042936) Bacteria identified in Isolate by Culture

682

3235

2.41

81.29

2.6

1.9

—

(3042733) HLA Ab [Presence] in Serum

12.66

79.65

4.5

4.8

—

(3024928) Oxygen saturation in Venous blood

179

384

4.88

78.25

4.5

2.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1603

10719

1.99

77.63

6.1

4.7

34.2

35.6

g/l

16.54

1498

9902

(3002582) Erythrocytes [#/volume] in Urine

1248

7645

2.04

77.54

4.0

3.2

79.8

94.2

e6/l

0.21

977

5859

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1238

7618

2.02

75.45

3.4

3.3

42.5

36.6

u/l

0.83

1173

7165

(3010375) cycloSPORINE [Mass/volume] in Blood

9.41

74.15

28.5

25.5

115.5

115.4

ug/l

0.00

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

186

442

4.41

71.59

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

186

442

4.41

71.59

1.4

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1359

8790

1.95

70.42

4.7

3.6

69.0

98.4

e6/l

1.43

1021

6253

(3026493) Urate [Moles/volume] in Serum or Plasma

1080

6494

2.00

68.88

3.6

2.5

1974.9

5336.5

umol/l

3.52

938

5606

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

339

1228

2.97

68.79

16.3

8.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

795

4313

2.12

66.90

3.3

2.8

1.2

1.1

e6/l

0.18

453

2458

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

395

1577

2.72

66.72

1.7

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

123

218

5.83

66.48

1.6

1.3

28.0

37.0

g/l

8.46

100

205

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

145

299

5.03

66.33

1.5

1.2

2.8

3.2

u/ml

0.30

123

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

496

2225

2.45

65.76

2.5

40.9

61.5

u/l

0.47

426

1931

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

165

383

4.49

65.39

1.5

109.0

113.3

u/ml

0.30

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

147

313

4.87

64.75

1.5

1.2

1.7

2.2

u/ml

0.65

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2447

19572

2.06

64.21

11.5

7.3

82.6

78.8

u/l

2.44

2350

18319

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

177

440

4.20

64.17

10.1

5.7

238.1

3893.5

iu/ml

0.55

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

751

4064

2.11

63.15

3.5

2.9

2.5

2.0

e6/l

0.83

408

2232

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

171

426

4.18

61.80

1.6

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

180

467

4.02

61.57

2.3

3.0

32.3

38.2

umol/l

1.49

158

396

(3023199) Leukocytes [#/volume] in Pleural fluid

112

203

5.68

59.10

1.6

1.3

9885.7

2546.3

e6/l

0.37

146

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

161

398

4.21

58.77

1.4

1.2

302.5

255.4

u/ml

1.13

120

247

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

339

1346

2.70

57.55

1.9

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

106

188

5.80

57.23

1.5

1.3

31727.1

92981.5

e6/l

1.24

109

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

224

711

3.31

56.68

2.3

2.1

0.0

0.1

g/l

1.02

201

651

(3045788) Cell count panel - Pleural fluid

157

6.27

56.28

1.6

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

211

648

3.42

56.27

2.3

2.2

0.0

g/l

0.00

189

600

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

267

950

2.98

55.62

4.4

2.3

0.6

0.7

1.54

260

908

(3007853) Bacteria identified in Skin by Aerobe culture

531

2625

2.23

55.56

2.2

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

476

2249

2.31

55.51

2.2

2.3

0.2

g/l

3.60

445

2115

(3000850) Epithelial cells [#/volume] in Urine

880

5241

1.94

55.51

3.0

2.5

5.4

4.6

e6/l

1.14

782

4541

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

212

660

3.37

55.32

2.3

2.1

0.0

g/l

0.15

189

603

(3012441) Differential panel - Pleural fluid

101

178

5.83

54.89

1.5

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

163

436

3.89

53.38

1.4

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

125

275

4.69

52.90

9.0

6.5

10.7

11.6

mg/l

1.30

111

253

(3023520) Reticulocytes [#/volume] in Blood

427

1967

2.35

52.65

2.5

2.4

74.1

66.6

e9/l

3.05

294

1480

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

104

197

5.42

52.32

2.5

2.4

—

(3026782) Osmolality of Urine

828

4918

1.92

52.15

3.2

2.7

530.7

570.5

mosm/kgh2o

7.12

714

4142

(3051611) Lipemic interference index of Serum or Plasma

110

220

5.14

52.08

5.9

3.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

133

316

4.35

51.10

1.3

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

222

749

3.11

50.67

2.3

2.1

36.8

38.4

g/l

3.48

197

627

(3024471) HLA-A [Type]

9.26

50.47

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

888

2.93

50.41

2.3

2.2

10.1

10.3

g/l

0.26

219

732

(3024932) HLA-DR beta [Type]

9.13

49.90

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

246

890

2.91

49.62

2.3

2.2

3.1

3.0

g/l

1.00

212

682

(3017143) Hepatitis C virus Ab [Presence] in Serum

459

2235

2.23

49.45

1.7

1.5

—

(3051651) Icteric interference index of Serum or Plasma

121

6.67

49.34

6.4

3.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

100

193

5.32

49.28

1.2

—

(4306422)

129

308

4.32

49.25

1.4

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

376

1694

2.38

48.59

5.0

3.6

126.4

81.8

ng/l

11.24

340

1465

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

233

828

2.96

48.53

2.5

2.2

0.6

1.2

g/l

1.79

204

701

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

254

949

2.82

48.25

2.3

2.1

3.7

3.8

g/l

0.82

210

666

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

254

950

2.82

48.15

2.3

2.1

7.4

g/l

0.09

213

697

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

254

950

2.82

48.15

2.3

2.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

205

689

3.11

47.05

3.2

3.3

3.2

1.8

ratio

0.60

(3034860) Kappa light chains.free [Mass/volume] in Serum

209

712

3.07

46.87

3.2

3.3

53.1

118.6

mg/l

0.41

177

597

(3048929) Epstein Barr virus Ab [Presence] in Serum

185

588

3.28

46.60

1.4

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

208

709

3.07

46.59

3.2

3.3

41.5

55.9

mg/l

0.61

176

595

(3021879) Hepatitis B virus core Ab [Presence] in Serum

336

1468

2.44

46.41

1.5

1.4

—

(3019060) Gas panel - Arterial blood

325

1403

2.47

46.07

6.4

4.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

162

477

3.52

46.04

1.6

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

190

619

3.20

45.95

1.9

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

1140

7738

1.73

44.96

3.1

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

475

2461

2.09

43.31

1.7

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2201

17919

1.73

43.21

4.7

3.6

15.3

14.8

pmol/l

12.45

2038

16009

(4268621)

202

4.87

42.86

3.1

2.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

546

2987

2.00

42.83

1.8

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

356

1657

2.29

42.43

2.4

2.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

296

1274

2.46

42.12

1.6

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

159

492

3.35

41.80

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

117

6.18

41.31

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

910

5920

1.75

40.97

3.1

2.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2010

16127

1.66

40.04

5.3

4.2

1971.7

2440.4

e6/l

0.12

248

(40768806) Pleura Pathology biopsy report

187

4.87

39.80

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

215

4.57

39.75

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

156

495

3.26

39.37

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

169

565

3.10

39.09

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

125

346

3.72

38.94

4.3

3.1

967.4

3916.9

u/ml

—

(3002385) Erythrocyte distribution width [Ratio]

2433

20616

1.75

38.64

35.8

15.6

14.2

13.6

44.78

2398

20112

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

462

2479

2.01

37.95

4.4

3.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

126

365

3.55

36.69

1.5

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

509

2867

1.92

36.18

1.3

548.4

531.9

titre

0.06

107

586

(3036782) Glucose [Moles/volume] in Pleural fluid

167

4.89

36.06

1.4

1.3

6.8

5.8

mmol/l

1.27

151

(44790049)

216

4.36

35.90

1.4

1.5

—

(44790047)

216

4.36

35.90

1.4

1.5

—

(44806118)

216

4.36

35.90

1.4

1.5

—

(44790048)

216

4.36

35.90

1.4

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

243

4.13

35.61

1.1

—

(3020891) Body temperature

213

850

2.61

35.41

7.5

4.3

—

(3034426) Prothrombin time (PT)

7.76

35.29

1.4

1.2

—

(3026008) Bacteria identified in Urine by Culture

1003

6957

1.64

34.35

3.3

3.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

178

4.64

34.34

1.2

1.3

120.0

148.5

titre

0.24

(3009871) Measles virus Ab [Titer] in Serum

7.18

34.33

1.2

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

196

767

2.66

33.88

2.4

2.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

169

613

2.85

33.79

5.1

3.6

1.9

1.4

mg/l

8.41

155

568

(3012501) Base excess in Blood by calculation

139

455

3.15

33.31

6.6

3.5

2.8

2.4

mmol/l

0.92

302

(40767503) Oxygen content in Capillary blood by calculation

136

440

3.18

33.24

3.5

2.3

16.4

16.7

0.28

242

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

154

4.83

32.52

1.5

1.3

851.0

475.8

u/l

0.24

144

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

360

3.39

32.42

1.4

—

(1616796) Gas panel - Central venous blood

139

464

3.09

32.22

5.9

3.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

129

412

3.22

32.21

1.6

1.7

—

(3010421) pH of Blood

154

547

2.91

32.00

6.5

3.4

7.4

1.26

136

443

(40760888) Immunoglobulin light chains.free panel - Serum

147

511

2.97

31.75

3.2

3.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

285

1374

2.18

30.87

10.3

6.4

24.4

24.5

mmol/l

0.12

276

1271

(3018405) Lactate [Moles/volume] in Arterial blood

187

757

2.56

30.15

6.3

3.7

1.5

1.3

mmol/l

1.35

180

749

(3036481) Cortisol [Moles/volume] in Serum or Plasma

369

1979

1.98

29.98

2.4

360.7

369.0

nmol/l

0.32

348

1822

(3028626) Oxygen [Partial pressure] in Capillary blood

138

488

2.91

28.91

3.9

2.7

8.4

8.3

kpa

0.09

129

453

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

151

561

2.78

28.86

1.5

0.2

g/l

0.58

138

530

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

154

579

2.74

28.77

1.4

1.5

1.2

g/l

0.90

143

545

(3024891) Influenza virus A+B Ag [Presence] in Specimen

145

529

2.82

28.68

1.2

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

853

5895

1.61

28.67

1.8

1.5

19.5

20.4

nmol/l

1.02

768

4956

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

285

3.52

28.40

1.4

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1467

11480

1.51

28.03

4.8

3.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1047

7643

1.55

27.54

3.0

2.5

59.7

59.5

u/l

0.04

982

7017

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

291

3.44

27.51

1.3

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2769

25023

1.78

27.29

29.3

12.5

24.2

25.6

mg/l

1.65

2442

19390

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

164

655

2.58

27.18

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

312

3.31

26.65

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1361

10567

1.50

26.52

2.2

2.0

89.8

94.2

pmol/l

2.96

730

5505

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

232

3.69

26.30

1.3

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

280

3.43

26.27

1.4

—

(3000492) Spirometry study

386

2213

1.85

25.43

1.6

1.4

—

(3011648) Oxygen content in Venous blood

158

4.24

25.17

2.3

1.9

10.9

10.6

0.18

158

(3028026) IgM [Mass/volume] in Serum or Plasma

262

1327

2.06

24.84

2.1

1.9

1.4

g/l

0.02

242

1198

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2527

22448

1.59

24.77

5.7

4.3

2.0

2.1

mu/l

0.43

2358

20138

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

201

922

2.26

24.52

2.2

1.9

1.4

2.4

ug/l

0.91

184

814

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.90

24.18

1.7

1.1

77.0

85.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2145

18432

1.50

24.12

5.3

3.9

15.1

11.9

mm/h

15.45

2009

16901

(3035880) pH of Pleural fluid

5.34

23.71

1.4

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

154

640

2.48

23.50

7.2

3.8

4.0

3.8

mmol/l

3.17

149

600

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.86

23.30

1.6

1.2

77.4

77.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

140

4.27

22.78

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

790

5613

1.54

22.67

3.8

3.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

310

1717

1.89

22.67

2.9

2.6

10.0

10.5

g/l

1.29

290

1563

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

131

516

2.60

22.35

1.4

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

616

4206

1.58

20.89

1.6

1.5

2.6

2.5

g/l

0.28

369

2480

(3006184) Hemoglobin [Mass/volume] in Capillary blood

124

503

2.52

19.94

2.8

2.0

131.6

131.1

g/l

0.07

350

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

4.50

19.85

1.2

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

4.50

19.85

1.2

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

242

3.24

19.82

1.5

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

223

3.33

19.68

1.5

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

130

4.13

19.63

1.5

1.2

16.4

14.1

u/l

0.10

125

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.18

19.56

2.1

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2859

26575

1.70

19.11

38.8

14.0

139.3

139.7

mmol/l

16.60

2818

25810

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

331

1969

1.76

19.08

3.7

2.5

50.1

68.5

ml/min/173m2

14.52

139

745

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

166

781

2.19

19.04

6.9

1.4

4.9

4.3

mg/l

0.19

148

540

(3019309) Folate [Moles/volume] in Red Blood Cells

668

4730

1.52

19.02

1.8

1.7

1201.0

1134.7

nmol/l

1.02

525

3497

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

12.92

18.55

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.72

18.51

1.3

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1089

8522

1.42

18.39

3.7

3.5

2.3

2.4

mmol/l

0.98

936

7356

(3037467) Urinalysis macro (dipstick) panel - Urine

1980

17162

1.40

18.25

5.0

4.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2861

26663

1.68

18.11

39.3

14.1

4.0

mmol/l

30.00

2818

25855

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

650

4619

1.51

18.09

2.8

3.2

2.5

mmol/l

2.16

548

4074

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.53

17.89

1.3

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

249

1386

1.86

17.85

4.4

3.1

2.3

1.5

mmol/l

1.48

182

998

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

248

3.07

17.77

3.5

4.1

—

(3021901) Oxygen saturation in Capillary blood

100

388

2.63

17.64

4.1

2.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

125

540

2.37

17.56

4.4

2.7

24.9

24.7

mmol/l

0.13

111

469

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

257

1459

1.83

17.30

4.4

3.1

5.1

kpa

0.22

233

1346

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

202

3.26

17.08

1.2

1.1

67.1

64.3

u/l

0.05

134

(3009343) pH of Capillary blood

253

1437

1.83

17.00

4.4

3.1

7.4

0.07

159

(21494890) Protein electrophoresis panel - 24 hour Urine

218

3.17

16.99

2.0

2.1

—

(3003181) Sodium [Moles/volume] in Urine

380

2.60

16.80

1.5

1.4

59.7

64.3

mmol/l

0.45

305

(3025941) Bacteria identified in Stool by Culture

212

1157

1.89

16.16

1.4

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

365

2.59

16.06

5.2

2.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

109

463

2.40

15.93

1.4

1.8

3.6

4.7

iu/l

0.53

151

(42529406) Shigella sp [Presence] in Stool by Culture

137

645

2.17

15.72

1.3

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2617

24074

1.47

15.66

28.9

12.0

72.9

79.7

ml/min/173m2

39.78

2382

19554

(3014765) Yersinia sp identified in Stool by Organism specific culture

136

640

2.17

15.63

1.3

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1004

7957

1.38

15.03

3.6

3.2

275.0

315.8

mg/l

0.14

700

5019

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

183

3.21

14.91

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

183

3.21

14.91

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

183

3.21

14.91

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

409

2.44

14.90

1.4

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1040

8301

1.37

14.87

3.5

3.2

7.1

7.9

mmol/l

9.36

880

6953

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

133

637

2.14

14.63

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

4.88

14.25

2.4

1.9

—

(3037756) Immunofixation for Serum or Plasma

106

473

2.28

13.89

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

125

597

2.14

13.86

1.2

219.2

85.3

titre

0.62

(3020682) Albumin/Creatinine [Ratio] in Urine

1038

8374

1.35

13.58

4.2

4.0

15.5

6.6

mg/mmol

4.60

701

5313

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.72

13.29

1.4

1.3

61.2

57.9

0.15

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.13

13.15

1.9

1.4

17.4

11.3

g/l

2.53

(3014891) Appearance of Pleural fluid

10.04

13.13

2.0

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

376

2.38

12.76

1.2

—

(3023419) Bacteria identified in Sputum by Culture

292

2.57

12.71

2.1

2.6

—

(3042631) Mycobacterium sp identified in Specimen

322

2.49

12.69

1.8

2.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

2468

22720

1.38

12.50

34.3

13.8

39.4

39.9

2.90

1828

15784

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

321

2.47

12.29

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.94

12.15

1.4

1.2

2.6

0.01

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1186

9879

1.32

12.12

2.6

2.1

76.1

78.3

nmol/l

1.67

1071

8703

(3024980) IgG subclass 4 [Mass/volume] in Serum

342

2.40

12.07

1.5

1.6

0.6

0.8

g/l

2.09

270

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

308

2024

1.58

11.96

6.0

3.5

1.2

mmol/l

6.29

287

1740

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

284

2.53

11.88

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

316

2.44

11.73

1.3

0.4

0.3

nmol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.29

11.47

2.3

1.8

28995.8

2909.8

e6/l

0.60

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2558

23778

1.38

11.47

6.8

5.8

41.5

40.0

mmol/mol

11.64

2410

21774

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

338

2.37

11.45

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

2784

26271

1.45

11.34

24.8

11.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.74

11.00

4.2

6.0

—

(3013512) EKG study

889

7188

1.33

10.98

6.2

3.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

390

2.24

10.92

1.1

1.3

32.5

35.0

u/l

0.07

327

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

10.42

2.0

0.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.43

10.39

4.2

6.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

5.15

10.30

4.2

6.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.82

10.20

2.3

2.1

601.8

502.9

e6/l

0.30

(3004451) EKG impression Narrative

3.57

10.19

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1382

11959

1.27

9.93

4.1

3.5

0.0

estimate

0.00

276

2197

(3024139) IgG subclass 3 [Mass/volume] in Serum

201

2.66

9.93

1.4

1.2

0.5

0.4

g/l

0.90

144

(3027135) IgG subclass 1 [Mass/volume] in Serum

201

2.66

9.93

1.4

1.2

7.8

6.5

g/l

1.06

148

(3028192) IgG subclass 2 [Mass/volume] in Serum

201

2.66

9.93

1.4

1.2

2.9

3.0

g/l

0.11

147

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

122

654

1.90

9.91

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1384

12018

1.27

9.53

5.5

4.7

0.0

estimate

0.50

283

2230

(3000093) Morphology [Interpretation] in Blood Narrative

218

2.55

9.45

1.2

1.1

—

(3025315) Body weight

8.60

9.35

4.7

2.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.60

9.35

1.0

1.1

—

(4062490)

202

2.60

9.31

1.5

1.3

—

(3036603) Volume of Urine

157

2.83

9.27

1.6

1795.4

1971.8

—

(3000494) Fungus identified in Specimen by Culture

394

2867

1.43

9.26

1.8

1.4

—

(1761868) Lipid panel - Serum or Plasma

705

8683

0.76

9.25

3.2

2.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1776

15915

1.26

9.24

3.7

3.0

72.8

50.3

u/l

10.91

1648

14635

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

192

2.63

9.17

1.1

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

163

978

1.70

9.12

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.27

8.99

1.3

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

6.27

8.99

1.3

1.0

87.5

103.5

0.68

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.49

8.83

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

108

3.17

8.77

1.1

1.2

1.1

ratio

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

112

1967

0.55

8.75

1.6

1.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

6.02

8.65

1.3

19.0

8.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.03

8.64

2.4

2.9

—

(21494755) Public health laboratory ask at order entry panel

113

1967

0.56

8.55

1.2

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

115

636

1.84

8.52

2.2

2.3

103.6

110.0

ug/min

0.08

389

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

159

2.73

8.50

2.0

2.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

182

2.61

8.50

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1386

12159

1.25

8.36

4.2

3.5

0.0

estimate

1.57

267

2147

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.99

8.33

1.2

61.1

84.9

1.99

(3003327) Ova and parasites identified in Stool by Light microscopy

118

665

1.80

8.24

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

273

2.26

8.08

1.3

—

nmol/l

—

(3044007) Cell count panel - Peritoneal fluid

3.77

8.06

2.4

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

170

2.61

8.01

1.5

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

631

5064

1.31

7.86

6.5

4.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

129

758

1.73

7.83

1.2

0.5

0.6

u/ml

0.10

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

122

2.89

7.74

1.7

1.5

6.5

4.6

u/l

0.26

(3003338) MCHC [Mass/volume]

2278

21200

1.26

7.72

40.0

16.4

330.0

333.2

g/l

48.44

2255

21031

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.73

7.62

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

374

2.03

7.58

1.2

55.1

36.7

u/ml

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.36

7.55

1.5

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

233

3328

0.68

7.54

4.8

4.6

32.0

32.1

0.06

177

2094

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.81

7.52

1.2

57.5

88.9

2.13

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1535

13727

1.23

7.42

2.8

2.6

—

(4035726)

324

2368

1.41

7.41

2.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

593

4761

1.30

7.32

1.2

2.3

1.9

u/ml

0.13

143

1207

(3017569) Oxygen content in Arterial blood

110

2.93

7.27

2.2

2.3

—

(40761535) Cells panel - Urine sediment

282

2020

1.43

7.22

4.1

3.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

445

1.91

7.17

3.8

3.6

60.2

56.8

1.55

445

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

2.64

7.13

1.3

1.5

—

(3047189) Immunofixation for 24 hour Urine

106

2.94

7.11

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

169

2.50

7.08

1.9

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.77

7.07

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

537

1.81

6.93

2.3

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

353

2.00

6.89

1.3

1.1

—

(40768797) Stomach Pathology biopsy report

441

3425

1.33

6.89

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

131

2.69

6.82

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

131

2.69

6.82

1.3

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

254

2.19

6.82

1.2

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

4.11

6.81

1.7

1.2

21.2

22.8

—

(40761536) Microorganisms panel - Urine sediment

277

2000

1.42

6.79

4.5

3.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

367

2778

1.36

6.79

1.7

1.8

1.6

1.5

1.53

306

2443

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.27

6.74

1.3

1.0

1.4

2.2

mmol/l

1.26

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

16.72

6.74

3.1

4.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1265

0.52

6.72

1.4

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

5.02

6.70

1.4

1.0

0.6

3.6

mmol/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.16

6.70

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

3.18

6.56

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.16

6.54

1.0

1.3

1.0

0.7

umol/24h

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.04

6.34

1.2

1.1

301.2

201.9

iu/ml

0.33

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

458

1.83

6.29

1.3

265.7

213.7

miu/ml

0.41

186

(3022313) Gas panel - Capillary blood

162

1073

1.54

6.15

4.5

3.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

151

2.47

6.10

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

151

2.47

6.10

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

151

2.47

6.10

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

387

1.88

5.94

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.69

5.92

1.7

2.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.12

5.88

4.0

2.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.42

5.86

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.42

5.86

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.42

5.86

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

418

1.84

5.85

1.2

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

167

2.35

5.81

1.8

2.2

13.6

14.4

0.11

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.92

5.72

1.2

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

150

2.42

5.70

1.6

1.4

6.1

6.4

u/l

0.11

122

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.20

5.59

1.3

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

282

2114

1.37

5.56

5.3

4.1

0.7

1.0

1.61

100

585

(3000475) Leukocytes [#/volume] in Synovial fluid

591

1.68

5.51

1.6

12093.5

11787.4

e6/l

0.04

410

(3042111) Morphology [Interpretation] in Bone marrow Narrative

399

1.82

5.43

1.9

1.6

—

(4010399)

233

1703

1.40

5.36

1.4

—

(3011412) CD3 cells [#/volume] in Blood

213

2.13

5.32

2.5

1.0

1.2

e9/l

0.88

128

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

162

2.30

5.28

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

138

2.41

5.21

2.3

2.9

35.1

35.9

—

(3044941) Cell count panel - Synovial fluid

383

1.82

5.20

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.77

5.03

15.8

4.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

199

2.13

4.98

2.1

2.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

375

1.80

4.93

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

106

676

1.59

4.82

1.4

1.6

0.1

13.2

iu/ml

0.77

130

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2519

24089

1.21

4.74

4.7

3.9

1.4

1.3

mmol/l

5.97

2340

21666

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.95

4.71

1.6

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.95

4.71

1.2

1.0

—

(3019977) pH of Arterial blood

114

2.47

4.70

2.6

7.4

0.34

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

141

965

1.48

4.66

6.4

4.8

1.7

1.6

0.74

136

907

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

274

1.91

4.63

1.4

1.5

65.9

58.2

0.67

174

(3029075) Extractable nuclear Ab panel - Serum

3.12

4.63

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

138

945

1.48

4.56

4.6

3.3

24.6

24.7

mmol/l

0.11

129

874

(21494434) Karyotype in Bone marrow

200

2.06

4.54

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

460

3788

1.25

4.52

1.3

30.7

38.3

iu/ml

0.68

136

1181

(3007930) Methemoglobin/Hemoglobin.total in Blood

139

956

1.47

4.50

6.4

4.8

0.8

0.9

1.59

134

900

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.83

4.38

1.8

2.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.24

4.35

1.5

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

119

2.36

4.32

1.0

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

251

1924

1.33

4.32

5.2

4.0

0.5

0.6

0.94

424

(3000570) Elastase.pancreatic [Mass/mass] in Stool

110

730

1.52

4.24

1.3

1.4

277.5

265.2

ug/g

0.25

410

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.63

4.22

2.0

2.4

27.0

27.6

0.06

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

843

9511

0.85

4.16

3.6

4.4

22.8

21.8

0.96

358

4847

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

122

832

1.48

4.14

1.7

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.60

4.13

2.2

2.5

11.4

12.5

0.09

(3021440) Promyelocytes/100 leukocytes in Blood

260

2016

1.32

4.13

5.4

4.2

0.1

0.99

548

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.54

4.13

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

158

1135

1.41

4.09

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

316

1.79

4.07

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

2.41

4.05

2.3

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

111

2.35

3.99

1.3

1.2

247.5

482.4

u/l

0.86

106

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

200

1502

1.35

3.96

1.3

26.5

60.0

au/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

112

2.33

3.92

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

112

2.33

3.92

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

112

2.33

3.92

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

112

2.33

3.92

1.9

—

(3025159) Blasts/100 leukocytes in Blood

245

1901

1.31

3.89

5.4

4.2

0.0

0.1

1.65

451

(3049717) Cytology report of Urine Cyto stain

152

1099

1.40

3.81

2.5

2.9

—

(3048689) Calprotectin [Mass/mass] in Stool

328

2651

1.26

3.80

2.0

2.3

148.2

152.0

ug/g

0.06

263

2076

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.84

3.79

1.6

1.5

9.9

8.6

ug/l

0.45

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

549

1.56

3.74

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

134

2.17

3.73

2.6

2.1

120.3

243.0

ug/min

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

154

2.09

3.72

1.0

1.1

—

(4034850)

118

819

1.46

3.70

17.8

8.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2804

27253

1.23

3.69

16.4

10.0

27.9

26.9

u/l

1.43

2720

26106

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

148

2.11

3.68

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

148

2.11

3.68

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

239

1.85

3.65

1.3

1.2

1.8

1.4

nmol/l

1.16

210

(3045716) Anion gap in Serum or Plasma

116

2.25

3.64

1.8

9.1

9.8

mmol/l

0.36

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.43

3.63

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.43

3.63

2.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

642

1.51

3.63

1.5

1.7

—

(3047181) Lactate [Moles/volume] in Blood

102

692

1.49

3.60

7.5

6.0

1.3

mmol/l

0.13

614

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

163

2.04

3.60

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

135

967

1.41

3.59

2.1

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.95

3.57

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.86

3.52

1.1

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.02

3.49

3.2

6.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

10.02

3.49

3.3

6.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

250

1.81

3.49

12.6

5.2

7.2

7.5

mmol/l

0.27

204

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.18

3.49

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.56

3.48

1.4

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.62

3.47

2.0

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

295

1.74

3.46

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

152

2.05

3.45

2.7

437.4

609.9

e6/l

1.11

128

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

428

3602

1.22

3.43

1.2

13.7

14.3

u/ml

0.06

147

1363

(3022145) Colonoscopy Study observation

341

2809

1.24

3.36

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

136

990

1.39

3.32

2.3

3.7

474.6

2720.8

u/ml

1.07

111

854

(3039443) Prostate specific Ag panel - Serum or Plasma

663

0.55

3.29

1.8

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

115

2.18

3.28

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

749

6647

1.17

3.27

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

173

1312

1.34

3.27

1.5

1.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.58

3.26

2.5

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

187

0.27

3.24

1.0

—

(3008295) Osmolality of Serum or Plasma

244

1.77

3.14

1.5

1.4

275.9

281.6

mosm/kgh2o

0.80

190

(3037121) Protein [Mass/volume] in Urine

113

805

1.42

3.14

2.8

3.4

0.3

g/l

0.38

348

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.96

3.13

1.8

1.9

—

(3000012) Reticulocyte production index

118

2.13

3.10

1.7

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

7.51

3.05

1.2

1.0

—

(36660697) Celiac disease serology panel - Serum

216

1707

1.28

3.04

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

210

1654

1.29

3.04

2.3

2.4

13.9

25.7

au/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

963

0.65

2.99

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

168

1288

1.32

2.97

1.4

1.3

248.7

262.0

u/ml

0.07

161

1179

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

134

2.02

2.95

1.1

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

186

1452

1.30

2.89

1.6

1.9

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.68

2.86

3.3

3.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

378

3210

1.20

2.78

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

141

1067

1.34

2.75

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

174

1.85

2.72

2.5

2.3

—

(3045414) Leukocytes [Presence] in Urine

147

1123

1.32

2.69

2.1

1.8

—

(3014271) Vancomycin [Susceptibility]

112

2.06

2.67

4.3

2.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

112

2.06

2.67

3.1

3.7

—

(3002256) Pathology report gross observation

398

3412

1.19

2.64

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

297

1.63

2.62

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

192

1.78

2.58

1.6

1.5

45.8

24.9

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

222

1.72

2.57

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1086

11721

0.89

2.56

4.2

5.1

2.5

3.4

ug/l

1.24

946

10548

(3044242) Glucose [Moles/volume] in Arterial blood

114

2.02

2.56

2.1

2.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

7.15

2.55

1.0

282.4

313.4

nmol/l

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

164

1.84

2.53

1.2

1.3

—

86.7

—

(3044927) Protein electrophoresis panel - Urine

240

1.68

2.47

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

102

2.07

2.47

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.82

2.46

1.0

1.2

2.4

1.7

umol/24h

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2652

25833

1.15

2.45

5.8

4.9

2.5

2.8

mmol/l

47.58

2488

23481

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2574

25025

1.15

2.43

5.0

4.4

1.3

1.4

mmol/l

44.35

2406

22706

(40768443) Skin Pathology biopsy report

140

1081

1.31

2.41

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

120

908

1.33

2.38

1.8

1.6

—

(3025130) Human papilloma virus identified in Specimen

175

1.78

2.38

1.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.26

2.37

1.6

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2594

25244

1.14

2.36

5.1

4.4

4.3

4.7

mmol/l

64.32

2434

23061

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

222

1.67

2.31

1.4

1.5

24.5

30.1

0.44

137

(3034891) Synovial lining cells/100 cells in Synovial fluid

112

1.97

2.30

1.4

4.0

3.7

0.04

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

540

1.42

2.23

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.11

2.22

5.1

7.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

100

2.01

2.20

1.1

2.0

2.5

11.0

nmol/l

1.19

(3047007) Chlamydophila sp Ab [Presence] in Serum

296

1.56

2.19

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

304

1.55

2.19

1.7

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

131

1671

0.77

2.18

1.5

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.13

2.18

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

526

1.42

2.18

1.3

1.2

6.1

9.4

u/ml

0.42

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

520

1.41

2.13

1.3

1.2

8.0

2.5

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

158

1263

1.26

2.12

1.1

1.2

196.7

142.7

iu/ml

0.54

444

(40768804) Tissue Pathology biopsy report

1095

10207

1.11

2.11

2.2

2.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.05

2.11

1.6

2.0

—

(40768446) Kidney Pathology biopsy report

2.05

2.11

2.3

1.5

—

(3042517) Benzodiazepines panel - Urine

5.01

2.07

2.4

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.91

2.07

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

161

1297

1.25

2.03

2.6

2.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

118

1.87

2.01

1.3

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

111

1.90

2.00

6.2

2.5

13.2

21.0

mu/l

2.07

106

(3025549) Creatine [Moles/time] in 24 hour Urine

3.34

1.96

1.1

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.34

1.96

3.4

5.9

95.0

50.8

ug/min

—

(3029937) Albumin [Presence] in Urine by Test strip

712

6508

1.12

1.94

4.8

3.8

0.0

estimate

0.24

267

2163

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.55

1.94

2.4

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

218

1.61

1.94

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.97

1.93

1.5

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.97

1.93

1.5

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.97

1.93

1.5

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.97

1.93

1.3

2.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

172

1.69

1.93

1.2

1.3

905.0

560.0

titre

—

(3045142) Bone marrow Pathology biopsy report

290

1.52

1.92

1.5

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.57

1.92

1.4

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.19

1.88

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

301

1.50

1.85

1.1

1.3

364.9

259.7

pmol/l

0.97

243

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2554

24933

1.12

1.84

5.2

4.6

6.2

6.0

mmol/l

12.60

2350

22475

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.58

1.80

1.1

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.92

1.80

1.8

3.0

41.0

160.9

umol/l

—

(3011985) Renin [Units/volume] in Plasma

321

1.47

1.76

1.3

1.4

75.1

65.4

mu/l

0.09

295

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

448

0.62

1.75

1.4

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

185

1.63

1.75

1.3

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.85

1.71

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.39

1.67

1.3

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

209

2456

0.84

1.66

2.2

12.4

13.0

nmol/l

0.52

180

2182

(3000330) Specific gravity of Urine by Test strip

156

1286

1.22

1.65

3.7

3.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.80

1.65

1.0

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

120

1.75

1.62

3.8

3.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.33

1.60

1.6

3.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

128

1.72

1.60

1.2

1.1

1.0

1.2

u/l

0.65

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

1.59

1.5

1.3

—

(40768800) Prostate Pathology biopsy report

819

0.74

1.55

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

233

0.51

1.53

1.0

30.9

44.6

ng/l

—

148

(40768795) Lymph node Pathology biopsy report

257

1.48

1.53

1.1

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.34

1.52

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

161

1.62

1.52

2.5

1.6

—

(44806071)

2.86

1.50

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

131

1.68

1.49

1.2

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

226

1.51

1.49

1.3

1.4

—

(40757373) Influenza virus identified in Isolate

2.23

1.46

1.4

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

285

1.44

1.45

2.5

1.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.73

1.43

4.8

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.04

1.43

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

110

1.73

1.42

1.2

1.4

6.8

7.1

ug/l

0.06

(3005011) Chlamydia sp Ab [Titer] in Serum

2.42

1.39

1.6

1.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

305

1.42

1.38

1.9

2.2

—

4.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

356

1.38

1.37

1.2

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.13

1.33

1.0

—

(3002619) Bacteria identified in Specimen by Culture

2.15

1.33

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.15

1.33

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.15

1.33

1.4

—

(3024263) Appearance of Synovial fluid

136

1.62

1.32

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.30

1.2

—

(40768441) Liver Pathology biopsy report

170

1.53

1.25

1.1

1.4

—

(3004775) Volume in Urine collected for unspecified duration

203

1.48

1.24

2.1

2.2

656.8

619.6

0.14

130

(3007461) Platelets [#/volume] in Blood

2866

28293

1.12

1.24

42.1

18.7

233.1

247.2

e9/l

22.90

2807

27399

(3035941) MCH [Entitic mass]

2867

28304

1.12

1.24

41.9

18.6

30.5

30.4

0.96

2826

27794

(3017704) Immunofixation for Urine

123

1.63

1.24

1.7

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

2868

28315

1.12

1.24

42.3

18.7

132.6

137.0

g/l

39.44

2830

27808

(3048879) Bone marrow aspiration report

1.86

1.23

2.3

1.9

—

(3024731) MCV [Entitic volume]

2867

28306

1.12

1.23

42.0

18.6

92.2

91.2

24.39

2827

27796

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

139

1.59

1.23

2.4

1.7

1.5

3.2

u/field

0.68

(3026361) Erythrocytes [#/volume] in Blood

2867

28308

1.12

1.22

42.1

18.6

4.4

4.5

e12/l

32.84

2806

27296

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.63

1.21

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.83

1.19

1.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2867

28314

1.12

1.19

42.1

18.7

7.1

6.7

e9/l

13.72

2803

27303

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.11

1.18

1.5

1.2

—

(3016750) Collection duration of Urine

141

1.56

1.17

2.0

2.1

484.2

494.2

min

0.19

105

(40765096) Chromosome analysis panel by Banding

1.78

1.16

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.05

1.15

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

600

1.26

1.12

1.7

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.34

1.12

3.1

1.5

133.7

154.8

ng/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

151

1.53

1.11

1.3

3.4

1.1

u/ml

0.39

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

192

1.46

1.11

1.3

1.5

0.2

0.3

nmol/l

0.39

155

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.96

1.11

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

209

1.44

1.10

1.2

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.38

1.09

2.2

2.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

313

1.35

1.06

1.9

2.2

859.1

2205.1

u/l

0.54

112

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

105

1.62

1.06

1.0

1.1

80.4

90.4

u/l

0.25

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

743

7005

1.08

1.06

1.5

1.6

1.5

1.4

mmol/l

1.06

619

5852

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

311

2820

1.11

1.04

2.8

4.5

7.7

24.0

ug/l

2.39

253

2326

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

482

1.27

1.03

1.5

1.9

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

106

1.61

1.02

1.0

1.1

16.8

36.0

u/l

0.94

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

617

1.24

1.02

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.92

1.02

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

273

1.36

1.01

1.1

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

282

1.35

1.00

4.2

4.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.81

0.98

1.1

1.4

—

(4146454)

331

0.69

0.97

2.9

2.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

513

1.25

0.97

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

140

1.50

0.97

1.3

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

132

1.52

0.97

1.1

1.4

—

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

158

1.46

0.93

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

144

0.55

0.93

1.1

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

144

0.55

0.93

1.1

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

145

0.55

0.92

1.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

145

0.55

0.92

1.1

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.73

0.92

1.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

142

1.48

0.92

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

151

1.46

0.90

1.0

1.1

0.1

8.6

nmol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

143

1.47

0.89

1.3

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.07

0.89

2.8

2.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

153

0.59

0.88

1.1

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

169

1.42

0.87

1.3

1.5

1.0

g/l

0.32

169

(3004809) Band form neutrophils/100 leukocytes in Blood

414

1.26

0.86

3.1

3.6

1.3

1.4

0.07

311

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.67

0.85

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

147

1667

0.88

0.84

3.2

4.6

4.1

e9/l

1.19

113

1239

(3038026) Centromere Ab [Units/volume] in Serum

191

0.63

0.84

1.2

1.1

—

52.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

206

1.36

0.81

2.4

2.0

0.8

2.0

u/field

1.14

(4024509)

236

0.68

0.80

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.79

0.0

2.4

—

0.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

173

1.39

0.78

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

461

0.78

0.76

1.4

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

186

0.64

0.76

1.2

1.1

—

68.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.67

0.74

1.7

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.84

0.73

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

107

0.56

0.72

1.2

—

(44813793)

142

1.41

0.72

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.58

0.71

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

661

6922

0.94

0.68

2.7

3.1

0.8

ug/l

0.26

469

4686

(3026389) Candida sp identified in Specimen by Organism specific culture

276

1.27

0.66

1.5

1.4

—

(4027681)

128

1.41

0.65

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

541

1.19

0.65

2.2

1.6

364.6

304.1

mu/l

0.52

502

(3041096) Erythrocytes [Presence] in Urine by Automated

615

6443

0.94

0.65

4.1

3.2

—

(4281824)

224

1.30

0.64

1.5

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.48

0.64

1.1

0.5

1.3

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.73

0.64

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

130

0.61

0.63

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

104

1.44

0.62

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

104

1.44

0.62

1.3

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.61

1.6

1.8

63.4

44.6

umol/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

564

0.83

0.60

4.3

3.1

29.4

27.6

mg/l

0.14

336

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

183

1.31

0.59

4.5

5.3

34.9

52.4

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

547

1.17

0.59

1.4

11.9

8.9

u/l

0.77

453

(3022621) pH of Urine by Test strip

175

1600

1.10

0.58

3.1

2.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

149

1.34

0.57

1.1

—

(40768793) Breast Pathology biopsy report

485

0.82

0.57

1.2

1.3

—

(3019225) pH of Specimen

244

2624

0.92

0.57

5.3

3.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

116

1.38

0.54

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.43

0.52

1.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

206

1.26

0.51

1.4

1.1

1.2

promille

0.15

161

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

127

1.34

0.49

6.2

6.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

624

1.14

0.48

1.5

1.4

29.0

29.9

iu/l

0.08

527

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.52

0.48

1.0

1.1

—

3.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

165

0.73

0.46

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

119

0.67

0.45

1.1

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

310

1.20

0.45

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

120

0.67

0.45

1.1

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

120

0.67

0.45

1.1

1.5

—

(4198724)

1.43

0.45

1.9

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.59

0.45

1.4

2.3

64.6

147.1

nmol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

530

5511

0.95

0.45

1.8

1.7

437.7

24983908.6

pmol/l

3.73

432

4543

(3000034) Microalbumin [Mass/volume] in Urine

253

0.79

0.44

2.9

3.3

40.9

30.4

mg/l

0.24

190

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.41

0.43

1.0

1.1

1273.7

1646.3

miu/ml

0.67

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.61

0.43

1.2

1.8

—

(3023410) Appearance of Cerebral spinal fluid

248

1.21

0.42

1.2

1.6

—

(4015189)

1.43

0.42

1.4

2.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.40

0.42

1.6

2.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

304

1.19

0.42

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

304

1.19

0.42

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.52

0.41

2.0

2.1

21.4

18.9

umol/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.41

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

3.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

689

0.88

0.41

4.7

4.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

105

1.33

0.41

2.0

2.3

—

(4094501)

662

1.12

0.41

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

305

1.18

0.40

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.39

0.40

1.2

35.2

39.9

g/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

306

1.18

0.39

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

102

0.69

0.39

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

252

1.19

0.38

1.1

—

3.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.33

0.37

1.2

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.35

0.37

1.2

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

355

1.16

0.37

1.9

1.5

—

(3008898) HLA-B27 [Presence]

693

0.89

0.36

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

272

1.18

0.36

2.9

3.6

64.6

57.0

1.29

161

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.27

0.36

1.7

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.65

0.35

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

733

0.90

0.35

1.7

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

443

1.13

0.34

3.5

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.30

0.33

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

274

0.84

0.32

1.4

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.28

0.32

8.5

7.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

339

3262

1.04

0.30

16.8

5.9

—

(3035933) Granulocytes/100 leukocytes in Blood

1.30

0.30

1.1

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.27

0.30

1.4

1.0

15.4

16.2

umol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.27

0.30

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

259

1.16

0.29

1.0

1.1

—

27.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

231

1.17

0.29

1.3

261700.2

125853.8

e6/l

0.22

157

(3028707) Methadone [Presence] in Urine by Screen method

251

1.16

0.28

4.8

2.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.28

0.28

1.1

0.6

1.1

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

242

1.16

0.28

1.1

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.27

0.27

2.9

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.27

0.27

2.9

2.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.23

0.27

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.23

0.27

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.23

0.27

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.23

0.27

1.3

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

104

972

1.07

0.27

3.1

3.7

85.3

58.6

u/ml

0.51

938

(3011288) Drugs identified in Urine by Screen method

366

1.12

0.26

8.0

3.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.70

0.26

1.8

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.69

0.26

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.68

0.26

1.8

1.7

—

(3019150) Specific gravity of Urine by Refractometry

512

5253

0.97

0.25

5.3

3.8

1.0

kg/l

0.84

814

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.27

0.24

1.1

—

4.7

—

(3016879) Cocaine [Presence] in Urine

543

1.09

0.23

3.7

2.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.32

0.23

1.4

2.7

1.1

1.2

mmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.27

0.22

1.3

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.22

0.22

1.6

3.1

1.1

1.2

mmol/l

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

116

1.21

0.22

1.9

1.2

68.8

61.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

305

1.12

0.21

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

8.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

0.80

0.20

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

1.18

0.19

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

239

2469

0.97

0.19

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

570

1.07

0.18

1.4

1.5

1272.1

589.9

e6/l

0.26

469

(3000764) Benzodiazepines [Presence] in Urine

580

1.07

0.18

3.6

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

100

1.20

0.18

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

246

2534

0.97

0.17

1.5

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.17

0.17

1.0

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

571

1.07

0.17

1.4

103.3

15.8

e6/l

0.48

447

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.76

0.17

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.73

0.17

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

263

1.10

0.16

1.1

0.7

3.0

u/ml

—

(3032773) Endomysium IgG Ab [Titer] in Serum

183

0.87

0.16

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.11

0.16

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

130

1.15

0.15

1.5

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

130

1.15

0.15

1.5

1.1

—

(4211845)

119

0.84

0.15

1.4

3.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

274

1.10

0.15

1.0

1.1

—

0.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

513

0.93

0.15

1.4

—

(44806420)

1.11

0.15

1.7

2.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

574

0.94

0.14

2.5

3.7

1115.3

846.2

u/ml

0.11

524

(3027008) Opiates [Presence] in Urine

586

1.06

0.14

3.6

1.9

—

(3027944) Amphetamines [Presence] in Urine

577

1.06

0.14

3.6

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

160

1.13

0.14

1.1

1.2

9.3

12.4

mmol/l

2.57

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.81

0.13

1.1

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

0.86

0.13

1.1

—

(3028300) Cannabinoids [Presence] in Urine

588

1.06

0.13

3.6

1.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

608

1.05

0.13

1.6

1.8

199.4

211.6

pmol/l

0.43

578

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

190

0.89

0.13

1.5

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

160

1554

1.03

0.12

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

272

0.92

0.12

1.2

1.1

3.0

2.4

u/ml

0.15

111

(3027923) C peptide [Moles/volume] in Serum or Plasma

146

0.89

0.10

1.2

1.3

1.0

1.1

nmol/l

—

110

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

222

1.08

0.10

1.1

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

107

1.12

0.08

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

322

1.06

0.08

1.9

1.8

16.0

23.3

mg/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

662

0.97

0.07

1.4

1.3

655.2

536.5

mg/l

1.06

629

(3044290) Cell count panel - Cerebral spinal fluid

521

1.04

0.07

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

285

0.95

0.06

1.0

1.1

2.1

2.0

u/ml

0.05

127

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

119

1.09

0.06

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

129

1.09

0.05

1.0

1.5

—

(3006462) Nitrate [Presence] in Urine

110

0.91

0.05

1.4

3.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

110

1.09

0.05

2.2

1.5

26.8

29.4

umol/l

0.57

104

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

109

0.92

0.04

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

230

1.04

0.03

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

548

1.02

0.03

2.3

1.7

1.2

0.8

nmol/l

2.45

456

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

338

0.98

0.01

1.1

0.2

1.8

u/ml

3.09

140

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

927

9254

1.00

0.01

4.7

3.7

—

(3005570) Glucose [Moles/volume] in Urine

237

0.97

0.01

1.5

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

303

1.02

0.01

1.3

1.1

—

(1002224) Polysomnography panel

932

1.01

0.01

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

214

1.03

0.00

1.1

1.3

2.4

2.0

mmol/l

0.52

203

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

256

0.98

0.00

1.3

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

304

1.02

0.00

1.3

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

105

1.05

0.00

1.5

1.3

23.9

27.3

umol/l

0.15

(3014133) Dog dander IgE Ab [Units/volume] in Serum

229

1.00

0.00

1.1

1.0

6.3

2.5

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

293

0.99

0.00

1.1

7.8

5.2

u/ml

0.40

150

(3023430) Cat dander IgE Ab [Units/volume] in Serum

213

0.99

0.00

1.1

1.0

3.4

4.4

u/ml

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.94

0.00

2.0

2.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.7

—

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.8

—

4.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.91

0.00

1.4

1.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1473.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

2.8

—

0.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.90

0.00

5.8

2.9

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1270.0

—

(3003129) Base excess in Capillary blood by calculation

0.85

0.00

2.6

1.6

-1.9

0.5

mmol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.5

—

3.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CARDMYOOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CARDMYOOTH	2.542 [2.24, 2.88]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.101

During the follow-up period (1.1.1998 — 31.12.2019), 1540 out of 5408 females with I9_CARDMYOOTH died.

Males

Parameter	HR [95% CI]	p-value
I9_CARDMYOOTH	2.934 [2.64, 3.26]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.034

During the follow-up period (1.1.1998 — 31.12.2019), 3551 out of 8905 males with I9_CARDMYOOTH died.

Mortality risk

Mortality risk for people of age

years, who have I9_CARDMYOOTH.

N-year risk	Females	Males
1	0.194%	0.628%
5	1.26%	3.754%
10	3.269%	9.214%
15	6.251%	17.151%
20	11.13%	27.492%

Relationships between endpoints

↥

Index endpoint: I9_CARDMYOOTH – Cardiomyopathy, other and unspecified

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cardiomyopathy, other and unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints